You are here

radioligands

Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial

Clinical Trials Arena

Wed, 07/24/24 - 11:35 am

Blue Earth Therapeutics

prostate cancer

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data

BioSpace

Fri, 04/5/24 - 11:37 am

prostate cancer

clinical trials

Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street

BioSpace

Mon, 12/18/23 - 10:14 pm

Point Biopharma

Lantheus Holdings

prostate cancer

Novartis eyes first-line use of Lutathera after trial win

Pharmaphorum

Mon, 09/25/23 - 11:41 am

clinical trials

neuroendocrine tumors

Novartis expands in radio-oncology again with $1.3bn Artios alliance

Pharmaforum

Wed, 04/7/21 - 10:35 am

precision medicine

Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds

Endpoints

Tue, 03/30/21 - 11:40 am